110 related articles for article (PubMed ID: 33419819)
1. The Prognostic Significance of Peritumoral Lymphocytes' Band-like Structure in Type II Endometrial Cancer.
Shimizu Y; Suzuki S; Ukai M; Hattori S; Yoshikawa N; Kajiyama H
Anticancer Res; 2021 Jan; 41(1):249-258. PubMed ID: 33419819
[TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer.
Sofopoulos M; Fortis SP; Vaxevanis CK; Sotiriadou NN; Arnogiannaki N; Ardavanis A; Vlachodimitropoulos D; Perez SA; Baxevanis CN
Cancer Immunol Immunother; 2019 Nov; 68(11):1733-1745. PubMed ID: 31598757
[TBL] [Abstract][Full Text] [Related]
4. Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer.
de Jong RA; Leffers N; Boezen HM; ten Hoor KA; van der Zee AG; Hollema H; Nijman HW
Gynecol Oncol; 2009 Jul; 114(1):105-10. PubMed ID: 19411095
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of tumor-infiltrating lymphocytes assessment with hematoxylin and eosin sections in resected primary lung adenocarcinoma.
Kim A; Lee SJ; Ahn J; Park WY; Shin DH; Lee CH; Kwon H; Jeong YJ; Ahn HY; I H; Kim YD; Cho JS
PLoS One; 2019; 14(11):e0224430. PubMed ID: 31743333
[TBL] [Abstract][Full Text] [Related]
6. Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer.
Song IH; Heo SH; Bang WS; Park HS; Park IA; Kim YA; Park SY; Roh J; Gong G; Lee HJ
Cancer Res Treat; 2017 Apr; 49(2):399-407. PubMed ID: 27488875
[TBL] [Abstract][Full Text] [Related]
7. The prognostic benefit of tumour-infiltrating Natural Killer cells in endometrial cancer is dependent on concurrent overexpression of Human Leucocyte Antigen-E in the tumour microenvironment.
Versluis MAC; Marchal S; Plat A; de Bock GH; van Hall T; de Bruyn M; Hollema H; Nijman HW
Eur J Cancer; 2017 Nov; 86():285-295. PubMed ID: 29059634
[TBL] [Abstract][Full Text] [Related]
8. Peritumoral tertiary lymphoid structure and tumor stroma percentage predict the prognosis of patients with non-metastatic colorectal cancer.
Wang Q; Shen X; An R; Bai J; Dong J; Cai H; Zhu H; Zhong W; Chen W; Liu A; Du J
Front Immunol; 2022; 13():962056. PubMed ID: 36189233
[TBL] [Abstract][Full Text] [Related]
9. B cells in tertiary lymphoid structures are associated with favorable prognosis in gastric cancer.
Sakimura C; Tanaka H; Okuno T; Hiramatsu S; Muguruma K; Hirakawa K; Wanibuchi H; Ohira M
J Surg Res; 2017 Jul; 215():74-82. PubMed ID: 28688665
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Tumor-Infiltrating Lymphocytes and the Tertiary Lymphoid Structures in HER2-Positive Breast Cancer Treated With Adjuvant Trastuzumab.
Lee HJ; Kim JY; Park IA; Song IH; Yu JH; Ahn JH; Gong G
Am J Clin Pathol; 2015 Aug; 144(2):278-88. PubMed ID: 26185313
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in patients with endometrial carcinoma.
Čermáková P; Melichar B; Tomšová M; Zoul Z; Kalábová H; Spaček J; Doležel M
Anticancer Res; 2014 Oct; 34(10):5555-61. PubMed ID: 25275055
[TBL] [Abstract][Full Text] [Related]
12. Obesity, lymphadenectomy and survival outcomes in intermediate to high-risk, early-stage endometrial cancer patients.
Linkov F; Edwards RP; Althouse A; Rauh-Hain JA; Del Carmen MG; Freese KE; Kelley JL; Olawaiye AB
Future Oncol; 2015; 11(4):607-15. PubMed ID: 25686116
[TBL] [Abstract][Full Text] [Related]
13. A New Model to Improve the Prediction of Prognosis of Endometrial Carcinoma by Combining Traditional Classification With the Presence of Tumor-infiltrating Lymphocytes.
Miyamoto M; Hada T; Ishibashi H; Iwahashi H; Kakimoto S; Suzuki R; Sakamoto T; Matsuura H; Tsuda H; Takano M
Anticancer Res; 2021 Feb; 41(2):1047-1053. PubMed ID: 33517314
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of intratumoral and peritumoral lymphocytes and lymphocyte score based on the histologic subtypes of cutaneous melanoma.
Park CK; Kim SK
Oncotarget; 2017 Feb; 8(9):14759-14769. PubMed ID: 28107203
[TBL] [Abstract][Full Text] [Related]
15. Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers.
Liu X; Tsang JYS; Hlaing T; Hu J; Ni YB; Chan SK; Cheung SY; Tse GM
Oncologist; 2017 Nov; 22(11):1316-1324. PubMed ID: 28701569
[TBL] [Abstract][Full Text] [Related]
16. Expression of PTEN and β-Catenin and Their Relationship With Clinicopathological and Prognostic Factors in Endometrioid Type Endometrial Cancer.
Sal V; Demirkiran F; Erenel H; Tokgozoglu N; Kahramanoglu I; Bese T; Turan H; Sofiyeva N; Calay Z; Arvas M; Guralp O
Int J Gynecol Cancer; 2016 Mar; 26(3):512-20. PubMed ID: 26894937
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of intratumoral lymphocytes and FOXP3 expression in tumor cells of endometrial cancer.
Iurchenko NP; Glushchenko NM; Buchynska LG
Exp Oncol; 2014 Dec; 36(4):262-6. PubMed ID: 25537221
[TBL] [Abstract][Full Text] [Related]
18. Tertiary lymphoid structures are associated with higher tumor grade in primary operable breast cancer patients.
Figenschau SL; Fismen S; Fenton KA; Fenton C; Mortensen ES
BMC Cancer; 2015 Mar; 15():101. PubMed ID: 25884667
[TBL] [Abstract][Full Text] [Related]
19. Expression of Myxovirus Resistance A (MxA) Is Associated with Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancers.
Lee SJ; Hwang CS; Kim YK; Lee HJ; Ahn SJ; Shin N; Lee JH; Shin DH; Choi KU; Park DY; Lee CH; Huh GY; Sol MY; Lee HJ; Gong G; Kim JY; Kim A
Cancer Res Treat; 2017 Apr; 49(2):313-321. PubMed ID: 27456948
[TBL] [Abstract][Full Text] [Related]
20. L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: pooled PORTEC trial results.
Bosse T; Nout RA; Stelloo E; Dreef E; Nijman HW; Jürgenliemk-Schulz IM; Jobsen JJ; Creutzberg CL; Smit VT
Eur J Cancer; 2014 Oct; 50(15):2602-10. PubMed ID: 25126672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
